Seventy strains of Clostridium difficile, all isolated from symptomatic patients, were found to be uniformly susceptible to ramoplanin, a new glycolipodepsipeptide antibiotic, and to four glycopeptides (vancomycin, teicoplanin, and two semisynthetic teicoplanin derivatives). Ramoplanin is recommended for further evaluation in the treatment of C. difficile-associated disease.
In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates od Clostridium difficile / Biavasco, Francesca; Manso, E.; Varaldo, Pietro. - In: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. - ISSN 0066-4804. - ELETTRONICO. - 35:(1991), pp. 195-197. [10.1128/aac.35.1.195]
In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates od Clostridium difficile
BIAVASCO, Francesca;VARALDO, Pietro
1991-01-01
Abstract
Seventy strains of Clostridium difficile, all isolated from symptomatic patients, were found to be uniformly susceptible to ramoplanin, a new glycolipodepsipeptide antibiotic, and to four glycopeptides (vancomycin, teicoplanin, and two semisynthetic teicoplanin derivatives). Ramoplanin is recommended for further evaluation in the treatment of C. difficile-associated disease.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
